Use of targeted oxidative therapeutic formulation in...

Details Use of targeted oxidative therapeutic formulation in... Use of targeted oxidative therapeutic formulation in...

A - Human Necessities

61

K

A61K 31/00 (2006.01)

Patent

CA 2565363

A pharmaceutical formulation and its use. The pharmaceutical formulation contains peroxidic species or reaction products resulting from oxidation of an alkene, such as geraniol, by an oxygen-containing oxidizing agent, such as ozone; a penetrating solvent, such as dimethylsulfoxide ("DMSO"); a dye containing a chelated metal, such as hematoporphyrin; and an aromatic redox compound, such as benzoquinone. The pharmaceutical formulation is used to effectively treat patients affected with diabetes and obesity.

L'invention concerne une préparation pharmaceutique et son utilisation. Cette préparation pharmaceutique contient une espèce peroxydique ou des produits de réaction résultant de l'oxydation d'un alcène, tel que le géraniol, par un agent d'oxydation contenant de l'oxygène, tel que l'ozone, un solvant de pénétration, tel que le diméthylsulfoxyde (DMSO), un colorant contenant un métal chélaté, tel que l'hématoporphyrine, ainsi qu'un composé d'oxydoréduction aromatique, tel que la benzoquinone. Cette préparation pharmaceutique permet de traiter efficacement des patients souffrant de diabète et d'obésité.

Affiliated with

Also associated with

Rating

Use of targeted oxidative therapeutic formulation in... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of targeted oxidative therapeutic formulation in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of targeted oxidative therapeutic formulation in... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2036276